MED logo

MEDIFAST INC (MED)

$12.36

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on MED

Market cap

$135852134

EPS

0.02

P/E ratio

35.8

Price to sales

0.27

Dividend yield

--

Beta

0.482233

Price on MED

Previous close

$11.83

Today's open

$11.92

Day's range

$11.87 - $12.47

52 week range

$10.36 - $21.11

Profile about MED

CEO

Daniel R. Chard

Employees

504

Headquarters

Baltimore, MD

Exchange

New York Stock Exchange

Shares outstanding

10991273

Issue type

Common Stock

MED industries and sectors

Consumer Discretionary

Personal Services

News on MED

OPTAVIA Survey Reveals 80% of Americans Lack Understanding of Metabolic Health Despite Its Major Impact to Overall Health and Wellbeing

BALTIMORE--(BUSINESS WIRE)--OPTAVIA, the science-backed, coach-guided lifestyle system, announced a new report “Metabolic Health in America: Awareness, Attitudes and Action.” The report includes findings based on an online survey conducted by OPTAVIA with KRC Research among a nationally representative group of U.S. adults ages 18–75, recruited to match U.S. Census demographics*. The data highlights a pressing concern: 80% of American adults lack understanding of metabolic health, yet many are e.

news source

Business Wire • Dec 9, 2025

news preview

Medifast Scientific & Clinical Affairs Team Showcases New Research in Metabolic Health at ObesityWeek Conference

BALTIMORE--(BUSINESS WIRE)--Medifast, the health and wellness company known for its science-backed, coach-guided lifestyle system, continues to lead the charge in addressing the growing health crisis of metabolic dysfunction by unveiling new research findings during ObesityWeek. Hosted by The Obesity Society in Atlanta, Georgia November 4–7, 2025, the annual conference for obesity researchers and clinicians centers on the latest developments in evidence-based obesity science: cutting-edge basic.

news source

Business Wire • Nov 13, 2025

news preview

Medifast's Q3 Loss Wider Than Expected, Sales Decline 36% Y/Y

MED's third-quarter results reflect pressure from fewer active OPTAVIA Coaches, but it is steering toward metabolic health for growth.

news source

Zacks Investment Research • Nov 4, 2025

news preview

Medifast, Inc. (MED) Q3 2025 Earnings Call Transcript

Medifast, Inc. ( MED ) Q3 2025 Earnings Call November 3, 2025 4:30 PM EST Company Participants Steven Zenker - Vice President of Investor Relations Daniel Chard - Executive Chairman & CEO James Maloney - Chief Financial Officer Nicholas Johnson - Chief Field Operations Officer Conference Call Participants James Salera - Stephens Inc., Research Division Presentation Operator Greetings, and welcome to the Medifast Third Quarter 2025 Earnings Conference Call. [Operator Instructions] As a reminder, this conference is being recorded.

news source

Seeking Alpha • Nov 3, 2025

news preview

Medifast Announces Third Quarter 2025 Financial Results

BALTIMORE--(BUSINESS WIRE)--Medifast (NYSE: MED), the health and wellness company known for its science-backed, coach-guided lifestyle system, today reported results for the third quarter ended September 30, 2025. Third Quarter 2025 Revenue: $89.4 million, with revenue per active earning coach of $4,585 Active Coaches: Independent active earning OPTAVIA® coaches of 19,500 Net Loss: $2.3 million or $0.21 loss per diluted share Strong Balance Sheet: $173.5 million in cash, cash equivalents, and i.

news source

Business Wire • Nov 3, 2025

news preview

Medifast Announces Strategic Shift to Metabolic Health with the Introduction of Metabolic Synchronization™

BALTIMORE--(BUSINESS WIRE)--Medifast (NYSE: MED), the health and wellness company known for its science-backed, coach-guided lifestyle system, today announced a strategic transformation, unveiling a new focus on holistic metabolic health. The company introduced Metabolic Synchronization™ — a breakthrough science that reverses metabolic dysfunction with a targeted reset of the body's metabolism. Research shows the company's comprehensive system activates strong and targeted fat burn to improve m.

news source

Business Wire • Oct 27, 2025

news preview

Medifast to Announce Financial Results for the Third Quarter Ended September 30, 2025

BALTIMORE--(BUSINESS WIRE)--Medifast (NYSE: MED), the 40+ year old health and wellness company known for its science-backed, coach-guided lifestyle system, will announce financial results for the quarter ended September 30, 2025 on Monday, November 3, 2025, after market close. The Company will host a conference call to discuss the results with additional comments and details. Company participants will be Dan Chard, Chairman and Chief Executive Officer, and Jim Maloney, Chief Financial Officer.

news source

Business Wire • Oct 21, 2025

news preview

Will Medifast's Strategic Endeavors Deliver Growth in 2025?

MED boosts growth efforts with new products, digital tools and an expanded OPTAVIA coaching network.

news source

Zacks Investment Research • Sep 19, 2025

news preview

Evidence Links 5 & 1 Plan® to Improved Metabolic Health Outcomes

BALTIMORE--(BUSINESS WIRE)--With more than 90% of U.S. adults classified as metabolically unhealthy1, the silent crisis of metabolic dysfunction continues to escalate. This condition can be linked to a range of challenges, including being overweight and having difficulty maintaining energy, vitality and long-term health and wellbeing. To address this issue, Medifast, the 40+ year old health and wellness company known for its science-backed, coach-guided lifestyle system, is reinforcing its comm.

news source

Business Wire • Sep 15, 2025

news preview

Medifast (MED) Up 6.5% Since Last Earnings Report: Can It Continue?

Medifast (MED) reported earnings 30 days ago. What's next for the stock?

news source

Zacks Investment Research • Sep 3, 2025

news preview

¹ Disclosures

Get started with M1

Invest in MEDIFAST INC

Open an M1 investment account to buy and sell MEDIFAST INC commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in MED on M1